<![CDATA[OOG - Crete 2011]]>

The Autumn 2011 meeting of the OOG was held as part of EVER at the Creta Maris Convention Centre near Heraklion, Crete, between the 6th and 9th October.

Please click HERE for the minutes of the Business meeting, written by the President of the OOG, Professor Sarah Coupland.

Extracts from the Programme Book are shown below.

Saturday, 8th October 2011
11:00 - 12:30 Second Morning SessionJOINT M. OOG Presentations 1 Danae
RJW de Keizer, Nikolaos E. Bechrakis

11:00 Moulin AP, Zografos L�Lausanne
TRPM1 and MITF expression in conjunctival melanocytic proliferations

11:10 Missotten G, De Keizer RJW, Spileers W, Blank L�Leuven, University, Amsterdam
Strontium brachytherapy in conjunctival melanoma

11:20 Coupland SE, Baudo MM, Lake SL, Kalirai H, Damato BE �Liverpool
Chromosomal alterations in iris melanoma

11:30 De Keizer RJW, Rassaq L, Marinkovic M, Verbist B, Versluis M, Van Duinen SG, Luyten GPM�Leiden
Role of 3.0 Tesla MRI in diagnosis and treatment planning of iridociliary and choroidal melanocytic tumours

11:40 Bechrakis NE, Giatromanolaki A, Sivridis E, Charitoudis G- Innsbruck, Alexandroupolis, Berlin
Autophagic activity in uveal melanomas

11:50 Van den Bosch T, Van Beek J, Vaarwater J, Verdijk R, Naus N, Paridaens D, De Klein A, Kilic E- Rotterdam
Percentage of aberrant cells in uveal melanoma correlates with the patient�s prognosis

12:00 Angi M, Kalirai H, Baudo MM, Biddolph S, Coupland SE, Damato BE� Liverpool
Genetic and histological heterogeneity in uveal melanoma: a peculiar case

12:08 Mouriaux F, Diorio C, Bergeron D, Berchi C, Rousseau A- Qu�bec, Caen
Are liver function tests relevant for early detection of liver metastasis of uveal melanoma?

13:45 - 15:15 FIRST AFTERNOON SESSION
JOINT M. OOG PRESENTATIONS 2 Danae
Edoardo MIDENA, Nathalie CASSOUX

13:45 PARROZZANI R, PILOTTO E, DARIO A, MIGLIONICO G, MIDENA E�Roma, Padova
PCR-based circulating melanoma cells detection in uveal melanoma

13:55 DESJARDINS L, LEVY C, LUMBROSO LE ROUIC L, CASSOUX N, PIPERNO-NEUMANN S, MARIANI P, SERVOIS V, DENDALE R, PLANCHER C, ASSELAIN B�Paris
Adjuvant intravenous therapy by fotemustine in uveal melanoma: a randomised study

14:05 DAMATO BE, HOPE-STONE L, SALMON P�Liverpool
Quality of life after treatment of uveal melanoma

14:15 HEIMANN H, KENAWY N, DAMATO BE�Liverpool
Verteporfi n photodynamic therapy of retinal optic disc haemangioma

14:25 CASSOUX N, ASSAYAG F, NEMATI F, FONTAINE JJ, AERTS I�Paris, Maison Alfort
Development of new models of orthotopic primary human retinoblastoma xenografts

14:35 HADJISTILIANOU D, DE FRANCESCO S, RENIERI A, MENCARELLI MA, MAROZZA A, DE LUCA M, MICHELI L,
MENICACCI C, CERASE A, GALLUZZI P�Siena
CNS abnormalities in retinoblastoma patients

14:45 MIDENA E, PARROZZANI R, DARIO A, MIGLIONICO G, BISOGNO G, FLORA GP�Padova, Roma, San Don� di Piave
Propranolol in the management of orbital and periocular pediatric hemangioma

14:55 VAN GINDERDEUREN R, MISSOTTEN G, VAN DEN OORD J�Leuven
Puzzling case of choroidal tumour: paraganglioma or neuroendocrine carcinoma, diagnosis and treatment options

16:30 - 18:00 SECOND AFTERNOON SESSION
JOINT M. OOG : BUSINESS MEETING Danae
Sarah COUPLAND

Agenda

1. Minutes of previous Business Meeting (Copenhagen, April 2011)
2. OOG elections
3. Financial report
4. OOG Website update
5. Nominations for membership to OOG
6. Update on current collaborative studies/new proposals
7. Details of next OOG Meetings
8. Any Other Business (AOB)
9. Closure of Business Meeting

Prof. Frederic Mouriaux (left) and Prof. Edoardo Midena (right) collecting Certificates of Appreciation, as they step down from the OOG Committee as former Treasurer and President.